Cerner and Xealth Collaboration: Working to Improve the Healthcare Experience and Empower Patients to Be Active Participants in their Treatment and Well-Being

Collaboration will Bring Digital Health Tools to Clinicians and Patients to Improve the Health Care Experience

August 6, 2020

Xealth, the leader in enabling digital health at scale, and Cerner Corporation (NASDAQ: CERN), a global health care technology company, are working to improve the health care experience and empower patients to be active participants in their treatment and well-being. As part of this agreement, Cerner and LRVHealth have together invested $6 million in Xealth.

At its core, the relationship between Xealth and Cerner aims to give patients their own digital data so they can be more engaged in their treatment plans. The Xealth platform is designed to help clinicians easily integrate, prescribe and monitor digital health tools for patients from one location in the EHR.

Care teams will be able to order solutions directly from the EHR to manage conditions including chronic diseases, behavioral health, maternity care and surgery preparation. Incorporating Xealth into Cerner’s technology and patient portal will provide easier access to personal health information and give care teams the ability to monitor patient engagement with the tools, as well as analyze the effects of increased engagement on the patient’s health care and recovery.

During the recent surge of COVID-19 across the world, tools that automate patient education, deliver virtual care, support telehealth and offer remote patient monitoring have become even more prominent, creating new methods to inform care decisions and keep care teams and patients connected.

“Today, we have the unique opportunity to improve people’s lives by allowing active participation in their own treatment plans,” said David Bradshaw, Senior Vice President, Consumer and Employer Solutions, Cerner. “Patients want greater access to their health information and are motivated to help care teams find the most appropriate road to recovery. Xealth and Cerner hope to make it easier and more convenient for patients and clinicians to accelerate health care in a more consumer-centric experience.”

The collaboration between Cerner and Xealth will provide care teams and patients convenience and help improve care accessibility. Better communications and engagement between patients and key members of their care team will create an experience that is connected across settings before, during and after a care encounter. Xealth powers more than 30 digital health solutions, connecting patients with educational content, remote patient monitoring, virtual care platforms, e-commerce product recommendations and other services needed to improve health outcomes.

“In order for digital health to have lasting impact, it needs to show value and ease for both the care team and patient,” said Mike McSherry, CEO and Co-Founder of Xealth. “We strongly believe that technology should nurture deeper patient-provider relationships and facilitate information sharing across systems and the care settings. It is exciting to work with Cerner to simplify meaningful digital health for its health partners.”

Cerner and LRVHealth join Xealth investors Atrium Health, Cleveland Clinic, Froedtert and the Medical College of Wisconsin, MemorialCare Innovation Fund, Providence Ventures and UPMC as well as Threshold Ventures, McKesson, Novartis, Philips, and ResMed.

“Combining our expertise in developing interactive digital solutions that improve the patient experience with Cerner’s world-class platforms creates immense opportunity for our clients to better meet the needs of today’s highly connected health care consumer,” concluded McSherry.

SourceXealth

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”